Screening/Prevention Cervical Cancer


Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading

HPV Test Outperforms Pap Test for Detecting Cervical Abnormalities (May 25, 2011)

A test for high-risk types of human papillomavirus (HPV) is better than the Pap test at detecting cervical cancer. In addition, conducting cervical cancer screening every three years (rather than every... Continue Reading

New HPV Test Approved (April 22, 2011)

A new human papillomavirus (HPV) test—intended to detect women at highest risk of serious cervical abnormalities—has been approved by the US Food and Drug Administration (FDA). In addition to providing... Continue Reading

Fewer Lung Cancer Deaths Among Women (April 11, 2011)

The lung cancer death rate among women appears to be declining for the first time in 40 years, according to an annual report published by multiple institutions. Findings from the report were recently released... Continue Reading

Testing for Individual Types of HPV May Be Important (March 3, 2011)

Persistent infection with a high-risk type of human papillomavirus (HPV) is the principal cause of cervical cancer, and HPV testing can play an important role in cervical cancer screening. A study recently... Continue Reading

HPV Vaccine Protects Against Genital Warts and Precancerous Growths (July 30, 2010)

Results from a recent international study indicate that the vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) protects against genital warts and low-grade... Continue Reading

Many Physicians Fail to Adhere to New Cervical Cancer Screening Guidelines (July 12, 2010)

Apparently, old habits die hard: less than one-third of physicians report compliance with the updated guidelines for cervical cancer screening that suggest longer intervals between screening for women... Continue Reading

Getting Your Head Around Human Papillomaviruses (May 4, 2010)

You may have heard about HPV’s role in cervical cancer, but what about head and neck cancer? By Kari Bohlke, ScD Human papillomaviruses (HPV) have been in the news a great deal lately, but how much do... Continue Reading

More Than Half of Young Adults in New Relationships Infected with HPV (April 26, 2010)

More than half of young adults in a new sexual relationship are infected with human papillomavirus (HPV), and of those 44% were infected with an HPV type that causes cancer, according to the results of... Continue Reading

Cervical Vaccine Provides Little Benefit for Older Women (March 4, 2010)

Women over the age of 40 are not likely to benefit from a vaccine designed to prevent human papillomavirus (HPV), according to the results of a study published in the Journal of the National Cancer Institute.1... Continue Reading

Cervarix® Protection Extends Beyond Six Years (February 12, 2010)

Cervarix®—a vaccine that reduces the risk of cervical cancer by protecting against two high-risk types of human papillomavirus (HPV)—remains effective for more than six years. These results were published... Continue Reading

January Is National Cervical Cancer Awareness Month (January 4, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

ACOG Updates Cervical Cancer Screening Guidelines (November 20, 2009)

The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21... Continue Reading

Second HPV Vaccine Approved in U.S. (October 16, 2009)

The U.S. Food and Drug Administration has approved Cervarix®, a vaccine against two high-risk types of human papillomavirus (HPV), for prevention of cervical cancer and cervical precancers. This is the... Continue Reading

FDA Advisory Committee Backs Second Cervical Cancer Vaccine (September 11, 2009)

A U.S. Food and Drug Administration (FDA) advisory committee has concluded that Cervarix®—a vaccine against two high-risk types of human papillomavirus (HPV)—is safe and effective for the prevention... Continue Reading

Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients (August 20, 2009)

The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in... Continue Reading

Pap Screening May Be Unnecessary for Teens (August 6, 2009)

American women undergo cervical cancer screening at a younger age than their European counterparts, but this early screening may be unnecessary and possibly even harmful, according to three studies recently... Continue Reading

Cervarix® Effective Against Cervical Precancers (July 9, 2009)

A vaccine against two high-risk types of human papillomavirus (HPV) reduced the risk of precancerous cervical changes in young women. These results were published in The Lancet. Human papillomaviruses... Continue Reading

« Previous PageNext Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS